Sign in

CIK 0001088856 · Large accelerated filer

CORCEPT THERAPEUTICS INC

Sign in to watch
Ticker
CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770487658
Phone
650.688.8803
Business address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
  1. 4 Shares withheld for taxes Chief Business Officer gave up 80,284 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Executive Officer gave up 306,846 shares (to pay taxes)
  3. 4 Gift Director gave 400,000 shares (gift)
  4. UPLOAD Other SEC-generated Letter
  5. 4 Planned sale Chief Development Officer sold 20,000 shares at an average $80.08 ($1,601,526)
  6. 4 Planned sale See Remarks sold 20,000 shares at $79.52 ($1,590,490)
  7. 4 Planned sale See Remarks sold 5,000 shares at $79.53 ($397,632)
  8. 4 Grant or award Chief Financial Officer acquired 356 shares (grant or award)
  9. 4 Grant or award Chief Business Officer acquired 448 shares (grant or award)
  10. 4 Planned sale Chief Executive Officer sold 40,000 shares at $79.77 ($3,190,796)
  11. 4/A Open-market sale Chief Development Officer sold 4,500 shares at $80.90 ($364,070)
  12. 144 Insider Sale of Securities
  13. 144 Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. 4 Open-market sale Chief Development Officer sold 4,500 shares at $80.90 ($364,070)
  17. 144 Insider Sale of Securities
  18. 4 Planned sale Chief Development Officer sold 20,000 shares at an average $75.36 ($1,507,122)
  19. 4 Planned sale See Remarks sold 5,000 shares at $73.65 ($368,245)
  20. 4 Planned sale Chief Executive Officer sold 40,000 shares at an average $74.58 ($2,983,119)

Page 8 of 103 · 2,050 filings